These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 6327851

  • 1. Complement-dependent, Epstein-Barr virus-neutralizing antibody appearing early in the sera of patients with infectious mononucleosis.
    Sairenji T, Sullivan JL, Humphreys RE.
    J Infect Dis; 1984 May; 149(5):763-8. PubMed ID: 6327851
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Inhibition of Epstein-Barr virus production in P3HR-1 cells by Epstein-Barr virus-seropositive human serum.
    Sairenji T, Bertoni G, Medveczky MM, Medveczky PG, Humphreys RE.
    Intervirology; 1991 May; 32(1):37-51. PubMed ID: 1849877
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Demonstration of EBNA (Epstein-Barr virus nuclear antigen) antibodies of different immunoglobulin classes.
    Czeglédy J, Gergely L, Váczi L, Szalka A.
    Acta Microbiol Acad Sci Hung; 1978 May; 25(4):237-43. PubMed ID: 224651
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Biological properties and viral surface antigens of Burkitt lymphoma- and mononucleosis- derived strains of Epstein-Barr virus released from transformed marmoset cells.
    Miller G, Coope D, Niederman J, Pagano J.
    J Virol; 1976 Jun; 18(3):1071-80. PubMed ID: 178913
    [Abstract] [Full Text] [Related]

  • 12. Relationship between antibody production to Epstein-Barr virus (EBV) early antigens and various EBV-related diseases.
    Ooka T, de Turenne-Tessier M, Stolzenberg MC.
    Springer Semin Immunopathol; 1991 Jun; 13(2):233-47. PubMed ID: 1664988
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Importance and diagnosis of Epstein-Barr virus infection].
    Kuljić-Kapulica N, Krstić L, Budisin A, Kapulica I, Bojić I, Malesević M, Kalinić-Andrić V.
    Vojnosanit Pregl; 1991 Jun; 48(4):313-6. PubMed ID: 1660212
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Radioimmunoassay for detection of antibodies to Epstein-Barr virus in human infectious mononucleosis serum specimens.
    Hutchinson HD, Ziegler DW, Feorino PM.
    J Clin Microbiol; 1975 May; 1(5):429-33. PubMed ID: 170314
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Epstein-Barr virus infections.
    Middleton PJ.
    Can Med Assoc J; 1974 Jan 05; 110(1):9-10. PubMed ID: 4358535
    [No Abstract] [Full Text] [Related]

  • 20. Immune deficiency predisposing to Epstein-Barr virus-induced lymphoproliferative diseases: the X-linked lymphoproliferative syndrome as a model.
    Purtilo DT.
    Adv Cancer Res; 1981 Jan 05; 34():279-312. PubMed ID: 6269372
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.